Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol
- 18 January 2005
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 379 (1) , 47-51
- https://doi.org/10.1016/j.neulet.2004.12.046
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Adrenergic regulation of bone metabolism: Possible involvement of sympathetic innervation of osteoblastic and osteoclastic cellsMicroscopy Research and Technique, 2002
- The Inhibitory Effects of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide on Osteoclast Formation Are Associated with Upregulation of Osteoprotegerin and Downregulation of RANKL and RANKBiochemical and Biophysical Research Communications, 2000
- THE NEUROPEPTIDE CALCITONIN GENE-RELATED PEPTIDE INHIBITS TNF-α BUT POORLY INDUCES IL-6 PRODUCTION BY FETAL RAT OSTEOBLASTSCytokine, 1997
- The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblastsBone, 1996
- The role of calcitonin gene-related peptide (CGRP) in macrophages: the presence of functional receptors and effects on proliferation and differentiation into osteoclast-like cellsBone and Mineral, 1994
- Mechanism of action of amylin in boneJournal of Cellular Physiology, 1992
- Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in ratsNeuroscience, 1991
- AMYLINAMIDE, BONE CONSERVATION, AND PANCREATIC β CELLSThe Lancet, 1989
- Effect of surgical sympathectomy on bone remodeling at rat incisor and molar root socketsThe Anatomical Record, 1987
- Innervation of Periosteum and Bone by Sympathetic Vasoactive Intestinal Peptide-Containing Nerve FibersScience, 1986